Doctiplus - We are allways here!

Mn-Sn: 8am to 9pm

Mental Health & Depression — Weekly Report — October 26, 2026

Home/Health Insights/Mental Health & Depression — October 26 – November 2, 2026
Vol. 7 · No. 47
DoctiPlus Care · Weekly Brief on Mental Health & Depression
Updated Monday · November 16, 2026
Mental Health & Depression · October 26 – November 2, 2026

Mental Health & Depression
Weekly Report

This week's data 75 new clinical trials registered across 10 countries, with 3,274 trials actively recruiting patients worldwide.
Week of October 26 – November 2, 2026
  • 75 new clinical trials registered across 10 countries.
  • 3,274 trials actively recruiting patients worldwide.
  • Notable trial: A Prospective Study of Anxiety, Depression, and Bipolar Disorder in People (2690 patients).
  • 2,915 new research papers published.
  • Top cited: "Increasing engagement with cognitive-behavioral therapy (CBT) using generative AI: a randomized c..." (Communications Medicine, 10 citations).
  • Drug safety: Most reported effect across tracked medications (sertraline, fluoxetine, escitalopram, venlafaxine, duloxetine) was Off Label Use.
  • 8 active drug recall alert(s) — see details below.

The week in numbers

Figures · October 26 – November 2, 2026
New Trials This Week
75.
registered Oct 26–Nov 2
Recruiting Now
3,274
active trials seeking patients
Countries
10
with active trials this week
Papers Published
2,915
new studies this week
Phase 3 Trials
0
late-stage trials this week
Fig. 01

Trials by country

Count · October 26 – November 2, 2026
United States
16
Turkey (Türkiye)
13
Not specified
7
China
4
Spain
3
France
2
Indonesia
2
Egypt
2
Saudi Arabia
2
Mexico
1
0 4 8 12 16
total
Fig. 02

Trials by phase

Distribution · October 26 – November 2, 2026

New clinical trials registered this week for Mental Health & Depression. Each trial links to its full record on ClinicalTrials.gov where you can find eligibility criteria, locations, and contact information.

§ 03

This week's new registrations

Click any header to sort

75 trials registered for Mental Health & Depression. Each links to its full record on ClinicalTrials.gov.

# Trial ↓ Phase ↕ Status ↕ Enrollment ↕ Country ↕
01 Short, Wordless Animated Storytelling to Promote Mental Health Help-Seeking in Young Adults: A U.S. Online Randomized Controlled Trial Mental Health & Depression · Stanford University (NCT07906015) Other Not Yet Recruiting 2,100 N/A
02 Effect of Birth Dance on Birth Beliefs Mental Health & Depression · Ergani State Hospital (NCT07903363) Other Completed 124 Turkey (Türkiye)
03 Effects of Positive Psychology on Hope, Gratitude, and Well-Being Mental Health & Depression · University of Gaziantep (NCT07895680) Other Not Yet Recruiting 60 N/A
04 Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital Biomarkers Mental Health & Depression · Korea University Anam Hospital (NCT07905378) Other Not Yet Recruiting 200 N/A
05 Motivational Interviewing Intervention for Families With Overweight and Obesity Mental Health & Depression · Universidad Autonoma de Baja California (NCT07893717) Other Active Not Recruiting 120 Mexico
06 Music Therapy and Sedation for Pain and Anxiety During Oocyte Retrieval Mental Health & Depression · Samsun University (NCT07898358) Other Not Yet Recruiting 146 Turkey (Türkiye)
07 Building Resilience Through Anxiety Virtual Education in PICU Survivors Mental Health & Depression · University of Rochester (NCT07906366) Other Not Yet Recruiting 70 United States
08 Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide Mental Health & Depression · Butler Hospital (NCT07898631) Other Not Yet Recruiting 35 United States
09 Psilocybin for Depression in Veterans Mental Health & Depression · VA Office of Research and Development (NCT07895134) Phase 2 Not Yet Recruiting 150 United States
10 Virtual Reality and Point-of-View Video Modeling for Dental Anxiety in Children Mental Health & Depression · Didem ATABEK (NCT07894744) Other Not Yet Recruiting 69 Turkey (Türkiye)
11 Mandala Coloring in Late Pregnancy Mental Health & Depression · Fidan Balkaya (NCT07906743) Other Not Yet Recruiting 186 Turkey (Türkiye)
12 Effects of Cognitive Restructuring Intervention on Competitive State Anxiety and Volleyball Skill Performance Among Female Collegiate Volleyball Players in Guangzhou, China Mental Health & Depression · Lyu Botao (NCT07898969) Other Not Yet Recruiting 96 China
13 Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use Mental Health & Depression · University of Michigan (NCT07903974) Other Not Yet Recruiting 12 United States
14 Acupuncture Combined With Transcutaneous Electrical Acupoint Stimulation for Constipation-Predominant Irritable Bowel Syndrome With Anxiety State Mental Health & Depression · The First Affiliated Hospital of Zhejiang Chinese Medical University (NCT07899944) Other Not Yet Recruiting 58 N/A
15 Effects of Climate Change Education on Pregnant Women Mental Health & Depression · Dicle University (NCT07903818) Other Completed 75 Turkey (Türkiye)
16 the Effect of the Preoperative Information Method on Intraoperative Anxiety and Postoperative Outcomes in AIS Patients: a Randomized Clinical Trial Mental Health & Depression · Gazi University (NCT07902674) Other Completed 42 Turkey (Türkiye)
17 Effect of Stress Ball Use on Perioperative Anxiety and Postoperative Pain in Parturients Undergoing Cesarean Section Mental Health & Depression · The Second Affiliated Hospital of Chongqing Medical University (NCT07900269) Other Not Yet Recruiting 208 China
18 Music Therapy in Post-Stroke Patients: A Clinical Trial Mental Health & Depression · Universidad de Granada (NCT07899034) Other Recruiting 84 Spain
19 GENERATİVE AI-SUPPORTED NURSİNG PROCESS EDUCATİON AND NURSİNG STUDENTS' LEARNİNG OUTCOMES Mental Health & Depression · Istanbul Medipol University Hospital (NCT07905040) Other Completed 173 Turkey (Türkiye)
20 Effect of Added Load on Map-Based Proprioceptive Training in Chronic Neck Pain Mental Health & Depression · Hacettepe University (NCT07900295) Other Completed 30 Turkey (Türkiye)
21 A Prospective Study of Anxiety, Depression, and Bipolar Disorder in People Mental Health & Depression · Second Affiliated Hospital, Zhejiang University, School of Medicine (NCT07903246) Other Recruiting 2,690 China
22 Pilot Study to Co-create and Implement a Multicomponent Intervention to Reduce Mental Health Stigma in Primary Care Mental Health & Depression · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (NCT07894354) Other Not Yet Recruiting 60 N/A
23 Assessment of the Seasonality of Depressive Symptoms in Adolescents Mental Health & Depression · University Hospital, Rouen (NCT07895758) Other Not Yet Recruiting 210 France
24 Daily Cognitive Failures and Medication Adherence in Fibromyalgia Mental Health & Depression · Mardin Artuklu University (NCT07904468) Other Not Yet Recruiting 70 Turkey (Türkiye)
25 RISE for PTSD and Substance Use Disorder in Veterans Mental Health & Depression · VA Office of Research and Development (NCT07903753) Other Not Yet Recruiting 30 United States
26 Effects of Dead Bug Exercises With and Without Diaphragmatic Breathing in Patients With Chronic Non-specific Low Back Pain. Mental Health & Depression · University of Management and Technology Lahore (NCT07905222) Other Not Yet Recruiting 34 Pakistan
27 Evaluation of Preoperative Anxiety in Digestive Surgery Mental Health & Depression · University Hospital, Rouen (NCT07897942) Other Recruiting 300 France
28 Bisoprolol Versus Cognitive Behavioral Therapy for Stress in Patients on Peritoneal Dialysis Mental Health & Depression · Universitas Sebelas Maret (NCT07899281) Phase 4 Completed 20 Indonesia
29 Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance Mental Health & Depression · Boston University Charles River Campus (NCT07898592) Other Not Yet Recruiting 50 United States
30 Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD Mental Health & Depression · VA Office of Research and Development (NCT07904000) Phase 2 Not Yet Recruiting 138 United States
31 Continuous Theta-Burst Stimulation for Obsessive-Compulsive Disorder: An Open-Label Study Mental Health & Depression · Anhui Medical University (NCT07896837) Other Completed 60 China
32 A Clinical Trial to Evaluate the Effects of A Supplement on Symptoms of Menopause and Overall Well-being Mental Health & Depression · Primal Harvest, LLC (NCT07903480) Other Not Yet Recruiting 40 United States
33 AI-Powered Sleep Hygiene Mentor for Adults Living With HIV Mental Health & Depression · Universitas Indonesia (NCT07894042) Other Not Yet Recruiting 100 Indonesia
34 Heat and Mental Health - PART 2 Mental Health & Depression · Hartford Hospital (NCT07903896) Other Recruiting 75 United States
35 CANCER SCREENING PROGRAM ON UNCERTAINTY, ANTİCİPATORY ANXIETY, CANCER AWARENESS, AND E-HEALTH LITERACY IN A STROKE PATIENTS Mental Health & Depression · Ondokuz Mayıs University (NCT07904247) Other Active Not Recruiting 88 Turkey (Türkiye)
36 Mobile-Based Resilience Intervention for Moral Injury, Compassion Fatigue, and Distress in ICU Nurses Mental Health & Depression · Alexandria University (NCT07896447) Other Not Yet Recruiting 160 Egypt
37 A Web-based Intervention Program for Postpartum Depression Mental Health & Depression · Babes-Bolyai University (NCT07902141) Phase 1 Recruiting 30 Romania
38 BEAR for Women Who Have Experienced Sexual Assault and Have Suicidal Thoughts Mental Health & Depression · Stanford University (NCT07902050) Other Not Yet Recruiting 36 United States
39 Microbiota Modulation for Psychiatry Patients Mental Health & Depression · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (NCT07899424) Phase 1 Not Yet Recruiting 62 N/A
40 Relaxation Techniques and Pilates for Menopause Symptoms Mental Health & Depression · Belen Díaz Pulido (NCT07897812) Other Active Not Recruiting 50 Spain
41 Acceptance and Commitment Therapy-Based Group Psychotherapy for Chronic Headache Mental Health & Depression · Saglik Bilimleri Universitesi (NCT07906119) Other Active Not Recruiting 72 Turkey (Türkiye)
42 Empathy and Communication Training Program for Psychiatric Nurse Specialists in Saudi Arabia (ECTP) Mental Health & Depression · Lincoln University College (NCT07902336) Other Completed 154 Saudi Arabia
43 AI Simulation to Reduce Stigma and Enhance Psychiatric Readiness in Nursing Students Mental Health & Depression · Alexandria University (NCT07896538) Other Recruiting 200 Egypt
44 A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Mental Health & Depression · Alkermes, Inc. (NCT07901179) Phase 2 Recruiting 180 United States
45 Peri-procedural Weighted Blanket Use for ECT Mental Health & Depression · Mayo Clinic (NCT07900646) Other Not Yet Recruiting 200 United States
46 Acceptance and Committment Therapy Combined With Ketamine in Difficult-to-Treat Depression. Mental Health & Depression · University of British Columbia (NCT07906496) Other Not Yet Recruiting 50 Canada
47 ASSESSMENT OF ORAL HEALTH AND ORAL HEALTH-RELATED QUALITY OF LIFE IN PATIENTS AGED 12-18 YEARS WITH EATING DISORDERS Mental Health & Depression · Ondokuz Mayıs University (NCT07896707) Other Completed 24 Turkey (Türkiye)
48 Efficacy of MAGNESIO TOTAL on Sleep Quality and Quality of Life in Adults Mental Health & Depression · José Enrique de la Rubia Ortí, Ph (NCT07894562) Other Not Yet Recruiting 55 Spain
49 Effects of Swimming and Tennis on Mental Health, Fatigue, and Sleep in Young Women Mental Health & Depression · Fahri Safa Çınarlı (NCT07906574) Other Completed 34 Turkey (Türkiye)
50 Caregiver and Child Anxiety, Relationships, and Daily Emotions ("CARE Study") Mental Health & Depression · Tulane University (NCT07902076) Other Not Yet Recruiting 280 N/A
§ 04

Adverse event reports

FDA FAERS · 2025 data

Adverse drug event reports compiled from the FDA's FAERS database for medications commonly prescribed for Mental Health & Depression. These reports reflect what patients and healthcare providers have reported — they do not confirm a drug caused the effect.

Reports by drug

DrugTop effectCount
sertraline Nausea 958
fluoxetine Off Label Use 508
escitalopram Fatigue 725
venlafaxine Off Label Use 734
duloxetine Off Label Use 667

Recalls & safety notices

§ 05 · 8 items this week

FDA drug recall notices for medications related to Mental Health & Depression. If your medication is listed, contact your pharmacist or visit fda.gov/safety/recalls for guidance. No recall listed does not guarantee safety — always consult your healthcare provider.

IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionU.S Nationwide StatusOngoing
Jul 15
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc DistributionNationwide in the US StatusOngoing
Dec 6
2024
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionNationwide within the United States StatusOngoing
Nov 24
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc DistributionUS Nationwide. StatusOngoing
Apr 14
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc DistributionUS Nationwide. StatusOngoing
Apr 14
2025
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionNJ, AZ, IN StatusOngoing
Jul 25
2025
IIClass

DULOXETINE

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

ManufacturerAjanta Pharma Ltd. DistributionNationwide within U.S StatusOngoing
Apr 29
2026
IIClass

DULOXETINE HYDROCHLORIDE

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

ManufacturerBreckenridge Pharmaceutical, Inc. DistributionNationwide within the United States StatusOngoing
Nov 24
2025
§ 06

Published research

2,915 papers

Recently published peer-reviewed studies related to Mental Health & Depression, sourced from PubMed and Semantic Scholar. Click any title to read the full paper, or expand the abstract for a quick summary.

# Study Journal Date Source
01 Longitudinal associations between loneliness and cognitive performance in older adults: evidence from intensive longitudinal assessment. Kang JE et al. 10.1080/13607863.2026.2750968
View abstract

OBJECTIVES: Higher loneliness has been linked to cognitive decline in older adulthood, yet its directionality remains unclear. Most prior studies rely on infrequent assessments, obscuring short-term variability and longer-term change. We examined longitudinal associations between loneliness and cognition in both directions using ecological momentary assessment (EMA) across annual measurement bursts. METHOD: Data were drawn from 318 older adults (ages 70-90) in the Einstein Aging Study. Participants completed up to six annual 14-day EMA bursts, including repeated measures of momentary loneliness and concurrent smartphone-based tasks assessing spatial working memory, processing speed, and associative memory. Multilevel growth models tested whether baseline loneliness predicted cognitive changes and whether baseline cognitive performance predicted changes in loneliness across bursts. RESULTS: Limited evidence was observed for longitudinal associations in either direction. Baseline loneliness did not predict change in most cognitive domains, and baseline cognitive performance did not predict change in loneliness. The only exception was associative memory, where higher baseline loneliness predicted a lower likelihood of error-free performance over time. Loneliness increased modestly across bursts, and depressive symptoms predicted higher baseline loneliness and steeper increases over time. CONCLUSION: Baseline cognitive performance did not predict subsequent changes in loneliness. When examined in the other direction, associations between loneliness and cognition appeared limited and domain-specific, with only associative memory showing a longitudinal association with baseline loneliness.

Aging & mental health 2026 Nov 1 PubMed
02 Ethnic enclave residence and mental health among community-dwelling Hispanic and Chinese older adults in New York City. Wang N et al. 10.1080/13607863.2026.2751573
View abstract

OBJECTIVES: More than half of New York City (NYC)'s older adult population are immigrants, and many live in ethnic enclaves. We assessed the associations of enclave residence, gender, living status, and education with depression and anxiety among older Chinese and Hispanic adults in NYC. METHODS: We analyzed data from 640 community-dwelling Hispanic and Chinese older adults aged 60 and older, drawn from 1,310 TRIO participants, to examine associations between enclave residence and depressive and anxiety symptoms assessed using the PHQ-9 and GAD-7. RESULTS: Among Chinese women, enclave residence was associated with lower anxiety symptoms. Chinese women reported higher anxiety scores than Chinese men outside enclaves but not within enclaves. Enclave residence was not significantly associated with depressive symptoms among Chinese participants. Among Hispanic older adults, gender emerged as a significant predictor: Hispanic women reported higher depression and anxiety severity compared to Hispanic men, independent of enclave status. CONCLUSION: Findings suggest that the association between enclave residence and anxiety differs by gender among Chinese older adults. Enclave residence was not significantly associated with depressive or anxiety symptoms among Hispanic participants. These patterns may inform assessment of mental health needs in these populations.

Aging & mental health 2026 Nov 1 PubMed
03 [Differential diagnosis of rheumatoid arthritis pain: the role of subjective DAS28 scores, joint ultrasound, and digital biomarkers in therapeutic decision-making]. Makkos G et al. 10.1556/650.2026.33672
View abstract

The purpose of this review is to examine the diagnostic challenges arising from the mathematical biases of the DAS28 index used in monitoring rheumatoid arthritis, as well as the psychological and neurobiological factors underlying patient-physician discordance. Furthermore, this paper aims to analyze the role of digital biomarkers in future decision-making. A structural characteristic of the DAS28 index is that its subjective components carry twice the weight of objective metrics. In cases of central sensitization, depression, or anxiety, this can result in "false-positive" disease activity, leading to unjustified and costly interventions, as well as ineffective therapy. Literature confirms that patient-physician discordance is one of the primary predictors of therapeutic failure, particularly in difficult-to-treat (D2T) cases. The application of the DAS28-P index can help identify pain-dominant phenotypes. Besides musculoskeletal ultrasound, new technologies, such as keystroke dynamics analysis or artificial intelligence-based imaging, offer objective measures to eliminate subjective biases. Modern rheumatological approaches should integrate psychological support, patient education, and pain modulation alongside immunosuppressive treatment. The implementation of digital biomarkers and hybrid care models not only improves the patient's quality of life but also generates significant system-level cost savings in healthcare. Orv Hetil. 2026; 167(44): 1764-1771.

Orvosi hetilap 2026 Nov 1 PubMed
04 Chronic disease burden and health-related quality of life among missouri adults. Lima Dos Santos SP et al. 10.1007/s11136-026-04422-6
View abstract

PURPOSE: This cross-sectional study examined associations between chronic disease burden, specific chronic conditions, and Short Form 36 (SF-36) health-related quality of life (HRQoL) scores among Missouri adults 18 years of age or older. METHODS: We analyzed survey-weighted data from the 2024 Center for Medical Epidemiology and Population Health Adult Health Survey (N = 547). The primary chronic condition count included cardiovascular disease, chronic respiratory disease, arthritis, diabetes, depressive disorder, non-skin cancer, and kidney disease and was categorized as zero, one, or two or more conditions. Obesity was examined as a condition-specific exposure and in sensitivity analyses. Survey-weighted linear regression models adjusted for age, sex, race/ethnicity, educational attainment, employment status, and rurality. The Benjamini-Hochberg procedure was used to control the false discovery rate across the 10 HRQoL outcomes. RESULTS: Overall, 30.0% of Missouri adults had two or more of the seven selected chronic conditions. Compared with adults with no chronic conditions, adults with two or more conditions had lower scores for nine of the 10 HRQoL outcomes after false discovery rate correction. The largest adjusted differences were observed for Role-Physical (β = -30.65; 95% CI, -46.56 to -14.74), Physical Functioning (β = -28.70; 95% CI, - 38.60 to -18.81), Bodily Pain (β = -28.28; 95% CI, -38.96 to -17.59), Social Functioning (β = -26.18; 95% CI, -35.43 to -16.92), and General Health (β = -24.18; 95% CI, - 30.75 to - 17.62). Physical Component Summary (PCS) was 12.82 points lower (95% CI, -16.98 to -8.66), and Mental Component Summary (MCS) was 6.10 points lower (95% CI, -9.47 to -2.73). Arthritis and cardiovascular disease had the strongest associations with lower PCS, while depressive disorder had the strongest association with lower MCS. In supplementary continuous-count models, each additional condition was associated with a 4.57-point lower PCS score and a 2.20-point lower MCS score. CONCLUSIONS: Greater chronic disease burden was associated with poorer physical and mental HRQoL among Missouri adults. Adding HRQoL assessment to chronic disease surveillance and clinical follow-up may help identify functional limitations and mental health needs that are not apparent from diagnoses alone.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2026 Nov 1 PubMed
05 Machine Learning Classification of Bipolar Disorder Across Mood States Using Natural Language Processing and Speech Analysis: Observational Study. Yamaguchi Y et al. 10.2196/98094
View abstract

BACKGROUND: Bipolar disorder (BP) affects 1% to 3% of adults worldwide, with diagnostic delays averaging 6 years and high initial misdiagnosis rates. The absence of objective diagnostic measures contributes to clinical uncertainty and suboptimal outcomes. OBJECTIVE: This study aimed to (1) develop a machine learning model for BP diagnosis and mood state classification using linguistic and acoustic features, (2) identify features associated with different mood states by comparing each with healthy controls (HC), and (3) explore whether features distinguish between mood states within BP. METHODS: We analyzed data prospectively collected over 7 years from 61 patients with BP and 99 HC across Japan. Speech samples were collected via semistructured interviews over 1 to 5 visits and analyzed cross-sectionally, using aggregated or single-visit observations per participant rather than within-person longitudinal modeling. We extracted 6373 acoustic features (openSMILE 3.0, ComParE 2016) and 211 linguistic features. Least absolute shrinkage and selection operator (LASSO)-regularized logistic regression with nested cross-validation and age- and sex-matched undersampling was used. Mood states were classified as depressive state (DS; Hamilton Depression Rating Scale-17 [HAMD-17] ≥8, Young Mania Rating Scale [YMRS] ≤7), state with manic/mixed symptoms (MS/MX; YMRS ≥8), or euthymic state (ES; HAMD-17 ≤7, YMRS ≤7). Seven classification tasks included BP vs HC, each mood state vs HC, and interstate comparisons. Feature importance was validated via permutation testing (<.05). Medication sensitivity analyses were performed. RESULTS: The model achieved high discrimination for BP vs HC (area under the receiver operating characteristic curve [AUC]=0.916, 95% CI 0.854-0.958; sensitivity 0.933; specificity 0.859) and strong performance for mood states vs HC (AUC=0.805-0.874). Acoustic features comprised 96% to 98% of the features achieving statistical significance (<.05), including mel-frequency cepstral coefficients, spectral characteristics, and voice quality measures, showing strong correlations with diagnostic probabilities (|ρ|=0.35-0.85) and symptom severity (HAMD-17: ρ=-0.51; YMRS: ρ=-0.37); 2 to 4 linguistic features per comparison also reached significance. With sample independence ensured for interstate comparisons, DS vs ES significantly exceeded chance (AUC=0.760, permutation =.03), whereas MS/MX vs ES (AUC=0.601, =.20) and DS vs MS/MX (AUC=0.569, =.30) did not, suggesting that markers primarily reflect persistent disease characteristics with partial state-associated components in depressive states. CONCLUSIONS: The combined acoustic-linguistic model, driven primarily by acoustic features, shows potential as an objective aid for BP diagnosis (AUC>0.9), largely free of medication confounding; some features remained detectable during euthymia, although ES discrimination could not be fully separated from concurrent antipsychotic treatment. Although DS showed partial distinguishability from ES, overall limitations remain for monitoring mood state changes. Findings require validation in diverse populations and against other psychiatric conditions.

Journal of medical Internet research 2026 Nov 1 PubMed
06 Internalized HIV Stigma, Depressive Symptoms, and Antiretroviral Therapy Adherence Among Pregnant and Postpartum Women With HIV in Ghana: A Cross-Sectional Study. Sorkpor SK et al. 10.1002/hsr2.73426
View abstract

BACKGROUND AND AIMS: Pregnancy and the postpartum period can present substantial psychosocial and HIV-care challenges for women living with HIV (WLWH), with potential consequences for psychological well-being, treatment engagement, and maternal and infant health. This study examined whether internalized HIV stigma mediates the relationship between depressive symptoms and antiretroviral therapy (ART) adherence among pregnant and postpartum WLWH in Ghana. METHODS: Structured interviews were administered during antenatal and postnatal care visits in private settings to 176 women receiving ART at 11 public health facilities in the Greater Accra Region. Validated measures were used to assess depressive symptoms, internalized HIV stigma, and self-reported ART adherence. We tested a simple mediation model with bootstrapped confidence intervals to evaluate the indirect association between depressive symptoms and ART adherence through internalized HIV stigma, adjusting for age. RESULTS: Approximately one-third (35.8%) of participants reported below-average ART adherence. Greater depressive symptom severity was associated with higher internalized HIV stigma, which was associated with poorer adherence. Although depressive symptoms were not directly associated with nonadherence, a statistically significant indirect association was observed through internalized stigma, consistent with an indirect-only mediation pattern. Age was not significantly associated with either stigma or adherence. CONCLUSION: Our findings suggest that internalized HIV stigma may help explain the association between depressive symptoms and reduced ART adherence among pregnant and postpartum WLWH in Ghana. The results support consideration of integrated approaches that address both mental health and stigma within maternal HIV care. Scalable models, including group-based therapy delivered by lay health workers, may offer opportunities to support ART adherence and well-being in resource-limited settings. These findings contribute to our understanding of how psychosocial factors may shape treatment engagement among WLWH and identify potential targets for future intervention research.

Health science reports 2026 Nov PubMed
07 A Dimensional Approach to PTSD After Drug-Facilitated Sexual Assault: Impact on Sexual Functioning. Lizarán M et al. 10.1155/da/6023533
View abstract

Sexual assault (SA) is linked to both posttraumatic stress disorder (PTSD) symptoms and sexual functioning (SF) difficulties, but the psychological consequences of drug-facilitated SA (DFSA) remain insufficiently characterized. This study primarily compared PTSD symptom profiles between DFSA and non-DFSA survivors, while secondarily examining SF deterioration and exploring associations between PTSD symptom profiles and SF impairment. Thirty-nine women who experienced an isolated SA within the past year (20 non-DFSA, 19 DFSA) and 35 nontraumatized controls were recruited. Participants with prior SA, trauma history, or previous psychiatric disorders were excluded. PTSD symptoms were assessed only in the survivor groups. Although both survivor groups met PTSD criteria at similar rates, DFSA survivors exhibited fewer and less severe symptoms, particularly in reexperiencing, distress, avoidance, and dissociation. Both survivor groups reported SF deterioration after the SA compared with pre-assault functioning. In exploratory linear regression analyses, greater hyperarousal severity, but not negative alterations in cognition and mood, was associated with greater SF deterioration. These findings suggest that DFSA is characterized by a distinct profile of PTSD symptoms despite comparable diagnostic rates, emphasizing the importance of moving beyond categorical PTSD diagnoses toward symptom-informed clinical assessment. Such an approach may facilitate more personalized trauma-informed interventions. The exploratory association between hyperarousal and SF deterioration provides preliminary evidence for a potential therapeutic target that warrants confirmation in larger prospective studies.

Depression and anxiety 2026 PubMed
08 Predictive biases in emotional perception: differential influence of mood and affective primes in individuals with and without mood disorders. Leclerc A et al. 10.1093/nc/niag072
View abstract

Predictive processing models perception as an interplay between top-down predictions and bottom-up sensory inputs. When signals are ambiguous, perception increasingly relies on prior expectations. In emotional contexts, mood and affective primes may act as endogenous and exogenous predictions, biasing emotional perception, particularly in mood disorders, where predictions may become overly strong or unstable. Eighty-four participants (53 healthy controls, HC; 31 with self-reported mood disorders) completed an online affective priming task on unambiguous and ambiguous (morphs) facial expressions, preceded by masked or unmasked faces. Participants rated target emotions and completed mood questionnaires. Principal Component Analysis extracted latent mood dimensions. Drift Diffusion Modeling (DDM) estimated cognitive processes underlying ambiguous face perception. In HC and bipolar disorder (BD), happy primes increased positive morph categorization, while in depression (DEP), masked sad primes increased negative categorizations more than in HC and BD. Masked primes accelerated responses to morphs in HC, while BD showed faster responses regardless of priming type, with stronger facilitation than HC and DEP. No reaction time priming effects were observed in DEP. DDM revealed pre-decisional biases induced by primes, while mood only subtly influenced evidence accumulation. Findings suggest group-specific predictive biases: HC used masked primes to resolve emotional ambiguity, BD showed stronger reliance on external cues regardless of priming type, and DEP showed reduced sensitivity to primes alongside a selective negativity categorization bias. These biases may underlie core clinical features of mood disorders and may point to new targets for interventions aiming to restore adaptive emotional inference.

Neuroscience of consciousness 2026 PubMed
09 Women Empowerment and Its Relationship With Anxiety and Depression Symptoms Among Currently Married Women in Bangladesh: A Nationally Representative Cross-Sectional Study. Rahman MM et al. 10.1155/da/7941286
View abstract

BACKGROUND: Mental disorders are prevalent, with women experiencing a higher incidence of mental health issues compared to men. The disparity in mental disorders may be attributed to women's disadvantaged social status. Data linking women's empowerment to mental health are limited. This study analyzes the relationship among currently married women in Bangladesh. METHOD: A sample of married women ( = 15,813) was obtained from the 2022 Bangladesh Demographic Health Survey (BDHS). The survey-based women's empowerment (SWPER) index was used to assess women's empowerment. The evaluation of anxiety and depression symptoms was conducted using the generalized anxiety disorder (GAD-7) scale and the Patient Health Questionnaire (PHQ-9). RESULTS: Attitudes toward violence and social independence were correlated with reduced adjusted scores on the GAD-7 (β-coefficients: -0.34 for attitudes toward violence and -0.16 for social independence) and PHQ-9 scales (-0.24 for attitudes toward violence and -0.13 for the social independence domain). However, the decision-making domain showed a positive association. Results also show that a unit increase in the standard deviation (SD) of the attitude toward violence score was associated with higher odds of moderate to severe anxiety symptoms (odds ratio [OR]: 0.79; 95% confidence interval [CI]: 0.68-0.91) and depression symptoms (OR: 0.80; 95% CI: 0.69-0.94). The social independence domain correlates with moderate to severe depressive symptoms, exhibiting lower odds (OR: 0.86; 95% CI: 0.75-0.99). CONCLUSION: This study identified associations between various dimensions of women's empowerment and mental health issues among women, highlighting the necessity of prioritizing women's empowerment within mental health initiatives in Bangladesh and similar contexts.

Depression and anxiety 2026 PubMed
10 The intergenerational and transgenerational effects of miRNAs in fertility, obesity and stress responses. Tang YC et al. 10.1093/eep/dvag035
View abstract

MicroRNAs (miRNAs) are key post-transcriptional regulators that play pivotal roles in diverse physiological and pathological processes. They primarily act by inhibiting protein translation and promoting degradation of messenger RNA (mRNA), thereby inducing post-transcriptional regulatory effects. Most miRNAs can travel through blood, in extracellular vesicles, and between maternal and fetal tissues. When altered miRNAs were present in germ cells, this induces epigenetic inheritance, which influences embryonic development after fertilization. Aberrant miRNA expression is associated with a wide range of human diseases. This review article will summarize current evidence on how miRNA dysregulation contributes to transgenerational effects on reproduction, metabolism, and stress-related phenotypes. This research focuses on the impacts of miRNAs on reproductive impairment, obesity, and stress-related phenotypes, and highlights evidence that these epigenetic changes can persist across multiple generations. Relevant studies were identified mainly through PubMed database using "miRNA" and "transgenerational effect", with a third keyword according to the topic of interest, including "reproduction", "hormones", "spermatogenesis", "obesity", "high-fat diet", "diabetes", "stress", and "therapy". In reproduction, environmental pollutants (including endocrine disruptors) can alter miRNA expression, impairing gonadal development, reducing primordial germ cells, inducing granulosa cell apoptosis, and disrupting sex hormone synthesis. miRNA-dependent pathways also affect spermatogenesis, sperm function, and oocyte development. In obesity, miRNAs regulate adipogenesis by modulating signaling pathways and transcription programs that control fat-cell formation. Paternal high-fat diet and gestational diabetes can shift miRNA profiles, raising offspring risk for obesity and metabolic disease. Chronic stress changes miRNA expression in germ cells and embryos, shaping stress reactivity and social behavior in later generations. Prenatal maternal stress is linked to lasting psychiatric vulnerability in offspring, with effects potentially persisting across multiple generations without continued stress. Overall, miRNA dysregulation can impair reproduction, metabolism, and stress responses, and these effects may be transmitted transgenerationally via epigenetic mechanisms.

Environmental epigenetics 2026 PubMed
11 Mini-Mental State Examination trajectories across dementia subtypes in the Swedish Registry for Cognitive/Dementia Disorders and U.S. National Alzheimer's Coordinating Center. Bao X et al. 10.1002/dad2.70531
View abstract

INTRODUCTION: Mini-Mental State Examination (MMSE) trajectories are widely used to describe cognitive decline in dementia, but estimates may be sensitive to cohort structure, follow-up density, and modeling assumptions. We compared subtype-specific MMSE trajectories across two complementary longitudinal data resources. METHODS: The analyzed data were from the Swedish Registry for Cognitive/Dementia Disorders (SveDem) and the U.S. National Alzheimer's Coordinating Center (NACC). Participants were included with at least two valid cognitive assessments separated by ≥ 90 days. The final cohorts included 30,115 SveDem participants and 33,429 NACC participants. Subtype-stratified regression-spline generalized additive mixed models and linear mixed-effects models were fitted with adjustment for demographic and clinical covariates. RESULTS: Compared with NACC, SveDem participants were older (median age 79 vs. 72 years), had lower baseline MMSE scores (22.3 ± 4.2 vs. 26.5 ± 4.6), and had shorter follow-up (median 1.9 vs. 3.2 years; mean cognitive assessments 2.9 vs. 4.5). Shared dementia subtypes showed broadly similar relative decline patterns across cohorts. In regression-spline models, Alzheimer's disease showed faster estimated annualized decline than vascular dementia in both SveDem (-0.79 vs. -0.49 MMSE points/year) and NACC (-1.22 vs. -0.24 points/year). Lewy body dementias and frontotemporal dementia showed intermediate but less consistent patterns. Absolute decline estimates varied by model specification, particularly where later follow-up was sparse. DISCUSSION: Relative subtype-specific MMSE decline patterns were broadly reproducible, whereas absolute long-horizon estimates required cautious interpretation. These cross-cohort reference patterns may support future dementia epidemiology studies using MMSE trajectories to compare subtypes, examine clinical factors or evaluate treatment-related associations.

Alzheimer's & dementia (Amsterdam, Netherlands) 2026 Oct-Dec PubMed
12 Modeling Consumer Adoption of Digital Mental Health Services (DMHS) in Indonesia: The Role of Desire. Adam MRR et al. 10.12688/f1000research.182672.2
View abstract

INTRODUCTION: The rapid growth of digital mental health services (DMHS) offers new opportunities to address unmet mental health needs, yet consumer adoption remains uneven, particularly in emerging economies. OBJECTIVES: Drawing on the model of goal-directed behavior (MGB) and the health belief model (HBM), this study develops and tests an integrated framework that positions desire to manage mental health as a central motivational mechanism underlying consumers' intention to purchase DMHS in Indonesia. METHODS: The study employed a quantitative research method, a self-administered online survey, among Indonesians aged 18-45 who had engaged in online shopping within the previous 6 months. Screening questions were used to assess the respondent's eligibility. The DAS-21 (depression-anxiety-stress) scales were used to measure the respondents' mental health condition with their consent. The PLS-SEM with SmartPLS was used to examine the proposed relationships. RESULT: The attitude toward purchasing DMHS and the subjective norm significantly influence desire, while perceived severity and perceived susceptibility also emerge as important motivational antecedents. Perceived behavioral control does not significantly affect desire, suggesting that instrumental capability alone is insufficient to activate emotional motivation in the mental health context. Importantly, desire exhibits a strong and positive effect on behavioral intention, confirming its role as the most proximal predictor of adoption intention. CONCLUSION: The study aimed to model consumer adoption of digital mental health services (DMHS) in Indonesia by integrating the goal-directed behavior (MGB) model with the health belief model (HBM), positioning the desire to manage mental health as a central motivational mechanism. The findings claim there is robust evidence that desire plays a pivotal role in translating cognitive evaluations and health beliefs into behavioral intention to purchase DMHS.

F1000Research 2026 PubMed
13 Feasibility of acceptance and commitment therapy for repetitive negative thinking versus internet-based CBT: a pilot randomised controlled trial in Swedish primary care among patients with anxiety, depression and stress. Bengtsson T et al. 10.1186/s40814-026-01951-2
View abstract

BACKGROUND: Repetitive negative thinking (RNT) is a transdiagnostic process relevant to common mental health problems in primary care. RNT-ACT is a brief acceptance and commitment therapy-based protocol targeting RNT in two sessions. This pilot study assessed the feasibility of RNT-ACT compared with therapist-supported internet-based cognitive behavioural therapy (iCBT) in Swedish primary care. METHODS: Thirteen participants were randomised: 7 to RNT-ACT and 6 to iCBT. The primary feasibility outcomes were recruitment rate, intervention non-completion, and patient satisfaction measured with the Client Satisfaction Questionnaire (CSQ-8). Symptom and process measures were secondary outcomes. Secondary outcomes were assessed at baseline and at 1- and 3-month follow-ups. Analyses were descriptive and exploratory, based on available observations without imputation of missing data. RESULTS: Thirteen of 20 eligible individuals were enrolled (65%), corresponding to 35% of all 37 individuals screened. All participants in the RNT-ACT group completed the intervention, whereas 4 of 6 participants in the iCBT group did not complete the intervention. Mean CSQ-8 scores were 27.8 (SD 3.7; n = 5) in the RNT-ACT group and 23.0 (SD 0.0; n = 2) in the iCBT group. CONCLUSIONS: The small sample size and high iCBT non-completion limit between-group comparisons. Further investigation of recruitment, treatment engagement, and patient and therapist experiences is needed before determining whether and how to proceed to a full-scale RCT. TRIAL REGISTRATION: ClinicalTrials.gov NCT05946382 registered July 14, 2023.

Pilot and feasibility studies 2026 Oct 31 PubMed
14 Longitudinal psychosocial burden, quality of life, and digital supportive care preferences before and after CAR T-cell therapy: a prospective single-center observational study. Fleischer A et al. 10.1186/s12885-026-17245-y
View abstract

BACKGROUND: Prospective studies of CAR T-cell therapy have described changes in patient-reported outcomes, but these are rarely examined alongside supportive care preferences and patients' own accounts. We examined these components together across the treatment course. METHODS: This prospective single-center study included adults scheduled for CAR T-cell therapy at a German tertiary hospital. Of 52 patients in the screening/recruitment log, 32 who completed at least three of four assessments formed the longitudinal cohort. Assessments occurred before treatment (T0), during post-infusion hospitalization (T1), at or around discharge (T2), and seven to eight weeks after discharge (T3). Standardized measures assessed quality of life, anxiety/depression, loneliness, fear of progression, somatic symptoms, and social support. Unadjusted generalized estimating equations examined longitudinal change; supportive care items were summarized descriptively and open-ended responses analyzed thematically. RESULTS: The cohort included 17 male and 15 female participants; median age was 61.0 years (IQR 53.0-65.5), and 23/32 (71.9%) had multiple myeloma. Global health status/quality of life showed an overall time effect (p = 0.001), with the lowest mean at T2 and recovery by T3. Physical functioning was nominally lower at T2 (β = -14.450, p = 0.046); fatigue was nominally higher at T1 and T2 (β = 11.990, p = 0.015; β = 15.574, p = 0.008), and the QLQ-C30 summary score lower at T1 and T2 (β = -7.772, p = 0.006; β = -6.954, p = 0.035). Loneliness was nominally higher at T1 (β = 0.795, p = 0.009), whereas PHQ-4 scores changed little. Across timepoints, 60.0% to 70.0% considered post-discharge psycho-oncological support useful and 66.7% to 79.3% considered peer contact useful. Five themes concerned treatment uncertainty, physical decline, multidimensional support needs, accessible individualized digital support, and incomplete treatment understanding. CONCLUSIONS: Patient-reported physical and functional burden was greatest during hospitalization and around discharge and improved by seven to eight weeks after discharge. Brief anxiety/depression scores captured only part of participants' support needs. The findings can inform co-design and prospective evaluation of longitudinal supportive care approaches without establishing intervention effectiveness.

BMC cancer 2026 Oct 27 PubMed
15 Racial Perceptions of Communication in Breast Cancer Diagnosis. Hora JA et al. 10.1007/s40615-026-03264-9
View abstract

AIM: To evaluate whether race affects how the healthcare team communicates with the patient, from the woman's perspective. METHODS: A cross-sectional study used the postoperative module of the BREAST-Q questionnaire to assess patients' perceptions of communication with the healthcare team. The questionnaire was applied to perioperative women after being diagnosed with breast cancer. The final sample consisted of 98 patients. The main outcome was the questionnaire score. Variables included self-reported skin color, professional type, and others. We used proper tests to compare the variables, and linear regressions to test independent variables. RESULTS: Of the 98 women analyzed, 54 self-identified as White (55.1%) and 44 as Black (44.9%). 58.1% of Black women responded that if they had a different skin color, their treatment would have differed, compared with 29.6% of the White women (p = 0.005). Regarding communication with breast surgeon staff, self-declared race, income, and work location negatively influenced the score. However, communication with nursing staff was only negatively affected by self-declared race and income. Moreover, only self-declared race influenced communication with support staff. In the multiple regression analyses, self-declared race was the only factor that, in isolation, negatively influenced communication between woman and staff. Satisfaction scores were most similar when communicating with the support team and least similar when relating to the breast surgeon. CONCLUSIONS: Self-reported race was the main factor associated with perceived poorer patient-staff communication during the diagnosis and initial treatment of breast cancer. Structural inequalities in communication should be addressed.

Journal of racial and ethnic health disparities 2026 Oct 31 PubMed
16 Quality of life, psychological well-being, and socioeconomic burden in survivors of total laryngectomy: A mixed-methods study from LMIC setting. Nemade H et al. 10.1007/s00405-026-10793-w
View abstract

BACKGROUND: Survivorship after total laryngectomy is associated with profound functional, social, and economic changes. While impairments in communication and employment are well recognised, their relationship with psychological well-being and quality of life remains less clearly understood, particularly in low- and middle-income settings (LMIC). METHODS: This cross-sectional mixed-methods study included 87 patients who had undergone total laryngectomy and were on follow-up at a tertiary cancer centre. Quality of life was assessed using the EORTC QLQ-H&N35, psychological distress using the DASS-21, financial toxicity using the COST-FACIT questionnaire, and social functioning using a structured social functioning questionnaire (SFQ-7). In-depth interviews were conducted in a subset of patients to explore the lived experiences of survivorship. Descriptive analyses were performed, and qualitative data were analysed using thematic analysis. RESULTS: Our study cohort included 87 survivors with a median age of 63 years and a median follow-up of 46 months. A substantial shift in employment status was observed following treatment, with unemployment increasing from 2.3% pre-treatment to 46% at the time of assessment. Financial toxicity was present in 41.3% of patients. Symptom burden was low across most EORTC QLQ-H&N35 domains, with greater burden primarily related to coughing and sticky saliva. Psychological distress was uncommon, with the majority of patients within the normal range for depression, anxiety, and stress. Social functioning was largely preserved, with only 5.6% reporting impairment. Qualitative findings described adjustment to post-treatment changes in communication and daily roles, with family support emerging as an important contextual factor. These findings may reflect adaptation among some survivors, although the underlying mechanisms cannot be established from this cross-sectional study. CONCLUSIONS: Survivors of total laryngectomy demonstrated relatively preserved quality of life and low psychological distress despite substantial changes in employment and financial status. The observed discordance between structural survivorship burden and perceived well-being may reflect differences in individual adaptation and social context, but these should be considered possible explanations rather than established mechanisms.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026 Oct 31 PubMed
17 Cannabinoid receptor type 1 availability in individuals with a history of childhood trauma: a positron emission tomography study. Mohammad Aghaei A et al. 10.1038/s41380-026-03931-7
View abstract

Early life adversity has a lasting impact on the endocannabinoid (eCB) system based on animal models. However, the impact of early life adversity, such as childhood trauma (CT), on the eCB system has not been thoroughly studied. We assessed the availability of cannabinoid receptor type 1 (CB1R) in individuals with CT compared to healthy controls without CT (HCs). Cannabinoid receptor type 1 (CB1R) availability was compared in adults with CT (N = 22) and age- and sex-matched HCs (n = 22), using positron emission tomography (PET) imaging with the CB1R-specific radiotracer [C]OMAR. Using linear models, the effect of the group was assessed on global and trauma-relevant brain regions (amygdala, hippocampus, and frontal cortex). Compared to HCs, lower CB1R availability was observed in CT globally (difference = -11.36%, F = 4.35, p = 0.04), in amygdala (-13.70%, F = 6.66, p = 0.01), and in hippocampus (-14.50%, F = 6.59, p = 0.01), but not in frontal cortex (-8.08%, F = 2.17, p = 0.14). There were no effects of a diagnosis of posttraumatic stress disorder (PTSD), major depressive disorder (MDD), nicotine dependence, or the use of antidepressant medication. This preliminary result of lower CB1R availability in adults with CT compared with HCs suggests eCB dysregulation associated with CT. Future studies should replicate and extend this finding and examine the potential effects of various trauma features on the eCB system.

Molecular psychiatry 2026 Oct 31 PubMed
18 Beyond the Sweet Spot: Hemispheric Asymmetry and Network Targeting in Depression DBS. Heilbronner SR et al. 10.1176/appi.ajp.20260971 The American journal of psychiatry 2026 Nov 1 PubMed
19 Furthering the Understanding of Psilocybin Use and Molecules Relevant to Depression and Schizophrenia. Kalin NH 10.1176/appi.ajp.20260960 The American journal of psychiatry 2026 Nov 1 PubMed
20 Toward Proteomic Biomarkers of Atypical Depression. Scheer E et al. 10.1176/appi.ajp.20260952 The American journal of psychiatry 2026 Nov 1 PubMed
21 Oldies but Goldies: The Targeted Antidepressant Effect of Electroconvulsive Therapy. Andreescu C et al. 10.1176/appi.ajp.20260900 The American journal of psychiatry 2026 Nov 1 PubMed
22 Cognitive impairment in uncontrolled vs controlled hypertension - systematic review and meta-analysis. Tyjas K et al. 10.1016/j.ejim.2026.107261
View abstract

INTRODUCTION: Hypertension is a well-recognized risk factor for the development of cognitive impairment (CImp) and brain vasculogenic lesions. The aim of this systematic review was to assess whether adequate blood pressure control, compared with ineffective treatment, reduces the risk of CImp and brain structural abnormalities. METHODS: Between June and July 2024, three databases (MEDLINE, Embase, PsycINFO) were screened for studies comparing cognitive performance or brain damage in hypertensive adults. 2,613 unique records were identified, and ultimately 18 predominantly cross-sectional studies were included. Meta-analyses using a random-effect model were performed for CImp prevalence in 5 studies, for Mini-Mental State Examination and Montreal Cognitive Assessment scores in 3 studies, for verbal fluency outcomes in 3 studies, and for white matter hyperintensities assessed in magnetic resonance imaging in 4 studies. RESULTS: The prevalence of CImp was lower in the group with well-controlled hypertension (OR 0.32, 95% CI: 0.13, 0.80), but the result was significant only among individuals ≥65 years of age. Similarly, white matter hyperintensities (WMH) tended to be less advanced among patients with controlled hypertension (SMD: 0.58, 95% CI: 0.08, 1.08). However, the individual neuropsychological tests analyzed (verbal fluency, delayed word recall, digit symbol substitution, and digit span) did not reveal significant differences between these groups. CONCLUSION: Adequate control of hypertension may be associated with a lower prevalence of CImp and less advanced WMH. However, the association with CImp was confined to older adults (≥65 years) and was based on a small number of studies with considerable between-study heterogeneity.

European journal of internal medicine 2026 Oct 31 PubMed
23 Safety and efficacy of cannabinoid-based interventions in Parkinson's disease: A frequentist and bayesian meta-analysis of randomized controlled trials. Fernandes JVA et al. 10.1016/j.neurol.2026.10.009
View abstract

INTRODUCTION: Idiopathic Parkinson's disease is a progressive neurodegenerative disorder with motor and non-motor symptoms that may remain inadequately controlled by conventional therapies. Cannabinoid-based interventions have emerged as potential symptomatic treatments, but clinical evidence remains limited and heterogeneous. We assessed their efficacy and safety using complementary frequentist and Bayesian meta-analyses of randomized controlled trials. METHODS: This systematic review followed PRISMA 2020. PubMed, Embase, and Cochrane Central were searched from inception through December 2025. Eligible studies were randomized controlled trials comparing cannabinoid-based interventions with placebo in adults with Parkinson's disease. Random-effects models pooled motor and non-motor disease severity, cognition, anxiety, depression, quality of life, and adverse events. Bayesian random-effects models were applied in parallel to characterize posterior treatment effects and uncertainty. RESULTS: Seven randomized controlled trials were included. Frequentist analyses did not identify clear differences between cannabinoid-based interventions and placebo across efficacy outcomes. Cannabinoid-based interventions increased the risk of confusion (risk ratio, 4.44; 95% confidence interval, 1.17-16.87) and dizziness (risk ratio, 2.78; 95% confidence interval, 1.65-4.68). Bayesian analyses showed posterior probabilities of any benefit of 74.0% for UPDRS III and 71.0% for cognition; probabilities of exceeding the prespecified standardized effect threshold of 0.20 were 42.8% and 54.8%, respectively, with substantial uncertainty across outcomes. CONCLUSION: Current randomized evidence is insufficient to establish clinically meaningful benefits of cannabinoid-based interventions in Parkinson's disease and suggests increased risk of some adverse events. Interpretation is limited by few trials and participants, short follow-up, intervention heterogeneity, and imprecise estimates.

Revue neurologique 2026 Oct 31 PubMed
24 Family Risk and Resilience Patterns Differentiate Early Childhood Vulnerability to Intergenerational Transmission of Abdominal Pain. Querdasi FR et al. 10.1016/j.jpain.2026.106482
View abstract

Children are at increased risk of developing chronic abdominal pain if a parent has an abdominal pain-related disorder of brain-gut interaction such as irritable bowel syndrome, suggesting family mechanisms of intergenerational pain transmission. However, patterns of family risk and resilience factors that predict children's vulnerability for developing chronic abdominal pain remain unknown. In a sample of parents with an abdominal pain-related disorder of brain-gut interaction and their young child without chronic pain, this cross-sectional study identified subgroups representing different constellations of family risk and resilience factors. It also tested subgroup differences on two vulnerability markers for children's future development of chronic abdominal pain: child emotional functioning and parental protective behavior. Baseline data from 212 parents and their 4-7-year-old child, participating in a randomized controlled trial testing a preventative intervention were included. Latent mixture modeling indicated a 3-group solution: (1) "High Socioeconomic Status, High Functioning" (55%) characterized by lower anxiety and depression and higher family resilience, (2) "Low Socioeconomic Status, High Pain Burden" (13%) characterized by higher pain catastrophizing and gastrointestinal symptoms, and (3) "High Socioeconomic Status, High Distress" (32%) characterized by higher parenting stress. Two of the three groups ("Low Socioeconomic Status, High Pain Burden" and "High Socioeconomic Status, High Distress" groups) showed lower child emotional functioning, and the "Low Socioeconomic Status, High Pain Burden" group also showed higher parental protective behavior, than the "High Socioeconomic Status, High Functioning" group. Results contribute to theoretical models of intergenerational pain transmission and help identify families who could benefit from preventative interventions. PERSPECTIVE: Among families of parents with chronic abdominal pain, low family resilience, low socioeconomic status, high parent pain burden, and high parent psychological distress may make young children more vulnerable to developing chronic abdominal pain in the future. These findings inform targeted interventions to prevent intergenerational transmission of abdominal pain.

The journal of pain 2026 Oct 31 PubMed
25 Limited Evidence for Non-Invasive Brain Stimulation as a Cognitive Enhancer in Neurodevelopmental Disorders: A Multilevel Meta-Analysis of Sham-Controlled Trials. Ying J et al. 10.1016/j.neubiorev.2026.107066
View abstract

Non-invasive brain stimulation (NIBS) is increasingly applied to ameliorate cognitive deficits in neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability, yet whether standardized scalp-based protocols produce reliable cognitive enhancement remains untested at scale. This study evaluates the transdiagnostic efficacy of NIBS on shared, non-core cognitive domains across NDDs, searching MEDLINE, PsycINFO, Embase, Web of Science, and the Cochrane Library from inception to January 2026. A three-level multivariate random-effects meta-analysis synthesized effect sizes while accounting for dependency among multiple outcomes contributed by the same study. From 9191 identified records (5237 after deduplication), 30 randomized sham-controlled trials yielding 178 effect sizes across seven cognitive domains were synthesized. NIBS did not significantly outperform sham for any domain: working memory (k=24; g=-0.16, 95% CI [-0.37, 0.05]), cognitive flexibility (k=11; g=-0.12 [-0.38, 0.13]), global executive function (k=8; g=-0.14 [-0.46, 0.18]), processing speed (k=8; g=-0.27 [-0.77, 0.23]), inhibitory control (k=4; g=-0.08 [-0.62, 0.46]), verbal fluency (k=5; g=-0.11 [-0.59, 0.38]), or self-monitoring/behavioral metacognition (k=4; g=0.13 [-0.60, 0.86]). The pooled cross-domain estimate reached nominal significance (g=-0.18, p=0.035) but fell below the small-effect threshold, and its wide prediction interval (95% PI [-1.01, 0.66]) spanned benefit and harm. Exploratory diagnosis-stratified analyses were likewise null in both ADHD and ASD (all p>0.10). Current unstandardized, "one-size-fits-all" NIBS protocols do not yield reliable cognitive enhancement across NDDs, exposing a translational bottleneck driven by methodological heterogeneity. Realizing NIBS therapeutic potential for cognition in NDDs will require a shift toward precision psychiatry, utilizing individualized neuro-navigation and state-dependent stimulation.

Neuroscience and biobehavioral reviews 2026 Oct 31 PubMed
26 Interventional Pain Medicine for Women's Health 10.1093/med/9780197820476.001.0001 Unknown Journal 2026 Scholar
27 DEPRESSION AND ANXIETY IN ADULTS WITH STAGE 5 CHRONIC KIDNEY DISEASE RECEIVING RENAL REPLACEMENT THERAPY: A SYSTEMATIC REVIEW J. S. Arum et al. 10.21776/ub.jppbr.2026.007.02.9 Journal of Psychiatry Psychology and Behavioral Research 2026 Scholar
28 The relationship between mental health disorders and LUTS. J. Janssen et al. 10.1016/j.autneu.2026.103422 2 citations Autonomic neuroscience : basic & clinical 2026 Scholar
29 Exploring the role of pain catastrophizing in anxiety and depression among breast cancer survivors Reza Akbarzade et al. 10.4103/jehp.jehp_212_25 Journal of Education and Health Promotion 2026 Scholar
30 Informant discrepancies in adolescent anxiety assessment: The roles of adolescent depression and school avoidance. Blair D. Batky et al. 10.1037/pas0001503 Psychological assessment 2026 Scholar
31 Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the Kingdom of Saudi Arabia M. Alajlan et al. 10.1007/s13555-026-01873-0 Dermatology and Therapy 2026 Scholar
32 Hubungan Depresi, Anxiety, dan Stres dengan Kepatuhan Pengobatan Tuberkulosis Paru Muhammad Akbar Bayu Sujiwo et al. 10.29313/bcsms.v6i1.22261 Bandung Conference Series: Medical Science 2026 Scholar
33 Building Emotional Awareness and Mental Health in Parenting (BEAM): protocol for a parallel-group randomized controlled non-inferiority trial for an app based intervention to improve postpartum mental health and support children’s brain development in Western Canada L. Tomfohr-Madsen et al. 10.1186/s13063-026-09849-3 Trials 2026 Scholar
34 Antidepressant drug use in Europe: past consumption, prescribing patterns and forecast until 2030 L. Bindel et al. 10.1007/s11096-025-02078-9 5 citations International Journal of Clinical Pharmacy 2026 Scholar
35 Predictors of psychiatric emergency department visits within twelve months post-inpatient psychiatric discharge in Alberta, Canada H. Elgendy et al. 10.1371/journal.pone.0351753 PLOS One 2026 Scholar
36 Worst-case scenarios, triggers, and coping strategies among head and neck cancer caregivers. Marilyn Horta et al. 10.1200/jco.2026.44.16_suppl.e18097 Journal of Clinical Oncology 2026 Scholar
37 Poster Session II - A314 IMPLEMENTATION OF ACCEPTANCE AND COMMITMENT THERAPY IN INFLAMMATORY BOWEL DISEASE: A SCOPING REVIEW C. Long et al. 10.1093/jcag/gwaf042.314 Journal of the Canadian Association of Gastroenterology 2026 Scholar
38 Increasing engagement with cognitive-behavioral therapy (CBT) using generative AI: a randomized controlled trial (RCT) J. McFadyen et al. 10.1038/s43856-025-01321-8 10 citations Communications Medicine 2026 Scholar
39 Exploring the Potential for African Hand Drumming in Alleviating Stress and Depression Among the Blind Community Yuan Ma et al. 10.1177/0145482X261454344 Journal of Visual Impairment & Blindness 2026 Scholar
DoctiPlus Health Insights are compiled weekly from public trial registries, FDA databases, and academic publishers. All figures reflect the seven-day window ending on the report date. Data is provisional and subject to registry updates.

Primary sources

  • ClinicalTrials.gov — public registry
  • openFDA — adverse events & recalls
  • PubMed / NCBI — research papers
  • Semantic Scholar — citations & papers

About this report

  • Category: Mental Health & Depression
  • Week: October 26 – November 2, 2026
  • Drugs tracked: New Trials This Week, Recruiting Now, Countries
  • Generated: November 16, 2026 at 6:48 AM
© 2026 DoctiPlus Care Vol. 7 · No. 47 · November 16, 2026 — 30 —